A Clinical Study to Evaluate the Effectiveness of Creatifix Juice Along with Standard Treatment in Patients with Chronic Kidney Disease

RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFECT OF CREATIFIX JUICE AS AN ADJUVANT MEDICINE IN THE MANAGEMENT OF CHRONIC KIDNEY DISEASES - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112881

Enrollment

Registered

2026-06-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient of Chronic Kidney Disease with G3b grade as per diagnostic criteria. Patients ready to give written informed consent

Exclusion criteria

Exclusion criteria: Past History of Dialysis Uncontrolled DM and HTN. Post-transplant patients. Severe comorbidities. Pregnant/lactating women. Pt having known allergy of ingradient of creatifix juice.

Design outcomes

Primary

Measure	Time frame
Change in renal function parameters, primarily estimated Glomerular Filtration Rate (eGFR) and serum creatinine levels, from baseline following administration of Creatifix Juice as an adjunct to standard treatment in patients with Chronic Kidney Disease.Timepoint: Assessed at Baseline (Day 0), Week 4, and Week 8.	—

Secondary

Measure	Time frame
Change in creatinine, urea, uric acid, proteinuria, & Serum Albumin KDQOL-36 quality of life scores.Timepoint: Assessed at Baseline (Day 0), Week 4, & Week 8 And post treatment	—

Countries

India

Contacts

Public ContactVIKRAM SINGH

Parul Institute of Ayurved

Vikramarichwal@gmail.com09671978866

Outcome results